BlackRock Health Sciences Trust (BME)
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end investment fund associated with BlackRock. The vehicle focuses on U.S. listed equities, with an emphasis on companies in health sciences and related areas such as medical, dental, optical, pharmaceutical, and biotechnology products, supplies, equipment, and services. Its portfolio may also use equity derivatives, including an option-writing approach. The fund is managed by BlackRock Advisors, LLC and measures its results against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was organized on March 31, 2005 and is domiciled in the United States.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-BME
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
September 15, 2026
|
September 30, 2026
|
3.1452
|
7.4%
|
—
|
—
|
—
|
—
|
547.7 M
|
—
|
—
|
—
|
—
|
52.8%
|
—
|